4.2 Article

Validation of the simplified Chinese version of PROMIS Parent Proxy-25 Profile in parents of children with cancer

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.pedn.2023.05.016

Keywords

Patient -reported outcomes; Parent proxy; Cancer children; Validation study

Ask authors/readers for more resources

The study aimed to assess the psychometric properties of PROMIS-25 in Chinese parents of children with cancer. The results showed that PROMIS-25 had good reliability and factor structure, and met the assumptions of item response theory. It can be an effective tool for evaluating symptoms in children with cancer.
Purpose: To determine the psychometric properties of the Patient-reported Outcomes Measurement Information System Parent Proxy-25 Profile (PROMIS-25) in a sample of Chinese parents of children with cancer.Design and methods: A cross-sectional sample (N = 148) of parents with children aged 5-17 years living with cancer was recruited. Each participant completed sociodemographic and clinical questionnaires and PROMIS25. The flooring and ceiling effects were calculated. Reliability was determined by the Cronbach's alpha and split-half coefficient. Factor structure was examined by factor analysis. Model fit and graphical plots were assessed to test the assumptions of Rasch model-based item response theory (IRT). Differential item functioning (DIF) was assessed in terms of gender, age, and treatment stage.Results: PROMIS-25 demonstrated some flooring and ceiling effect, excellent reliability (Cronbach's alpha > 0.7 for all six domains), and the six-domain factor structure was supported. The IRT assumptions were met in terms of unidimensionality, local independence, monotonicity, and measurement equivalence with acceptable DIF in terms of gender, age, diagnosis, and treatment stage.Conclusion: PROMIS-25 is a highly reliable and valid instrument for evaluating children with cancer that assesses important health-related quality of life domains of child cancer. Practice implication: Chinese parents of children with cancer and healthcare providers could use PROMIS-25 to assess the symptoms of children.(c) 2023 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available